North America
New Data Shore Up Evidence for Paired Tumor Origin, Molecular Testing in Cancer of Unknown Primary
Premium
Biotheranostics' CancerType ID can predict tumor origins for the majority of CUP patients, with reflex biomarker testing finding those eligible for targeted treatment.
Abbott, QuidelOrtho, Werfen, Others Gain 510(k) Clearances in August
The US Food and Drug Administration granted marketing clearances for immunoassays for a variety of infectious disease including syphilis, Lyme, and COVID-19.
Proteomics International Ends Licensing Deal With Sonic Health for Promarker D Test
The company said the parties had not met certain milestones required for commercialization of the test, which predicts risk of diabetic kidney disease.
Cancer Diagnostics Firm Syantra Raises $3.6M in Series A-1 Round
The University of Calgary spinout aims to commercialize a liquid biopsy test that measures mRNA biomarkers for the early detection of breast cancer.
GenomOncology, Precipio Partner on Myeloid Test Reporting
GenomOncology's Pathology Workbench will be used as the clinical genomic reporting platform for Precipio's myeloid neoplasm test.